EUCTR2010-022913-25-NL进行中（未招募）不适用
A prospective randomised open label study to determine the best dose escalation sceme of dipyridamol added to acetylsalicylic acid, based on the side-effect headache, in patients starting secondary preventive therapy for stroke - DOSE study
未提供0 个研究点目标入组 150 人开始时间: 2010年10月6日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •age over 18
- •Patients starting treatment with acetylsalicylic acid combined with dipyridamole according to Dutch treatment standards
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients not able to start treatment with acetylsalicylic acid combined with dipyridamole according to Dutch treatment standards
研究者
相似试验
已完成
不适用
A prospective randomised open label study to determine the best dose escalation scheme of dipyridamol added to acetylsalicylic acid, based on the side-effect headache, in patients starting secondary preventive therapy for strokeCVA / TIA10029305StrokeNL-OMON36298Albert Schweitzer Ziekenhuis114
尚未招募
4 期
A study to compare the safety and effectiveness of topical ozenoxacin vs mupirocin vs fusidic acid in impetigo contagiosa in pediatric age group.CTRI/2024/03/063414Ranjan Rashmiraj Sahu
进行中（未招募）
1 期
Iron treatment in patients with known kidney diseasepatients with known chonic kidney disease with functional or absolute Iron deficiency Anaemia, and are greater than 18 years will be given repleacement iron therapy accoring to current local protocols and NICE guidelinesMedDRA version: 15.0Level: LLTClassification code 10022973Term: Iron deficiency anaemiasSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2010-020452-64-GBHull and East Yorkshire Hospitals NHS Trust100
已完成
不适用
Clinical Trial to investigate the Safety and Efficacy of the BugSpeaks based personalized diet on the patients with Hyperglycemia and Hyperlipidemia.CTRI/2022/05/042791eucine Rich Bio Pvt Ltd60
招募中
4 期
Comparison of AgFix® foam dressing versus standard gauze dressing in treatment of grade II pressure ulcers.CTRI/2022/12/047886Dynamic Techno Medicals Private Limited